Immune responses to P falciparum antibodies in symptomatic malaria patients with variant hemoglobin genotypes in Ghana

Kwame Kumi Asare,Benjamin Agrah,Fiifi Solomon Ofori-Acquah,William Kudzi,Nii Ayite Aryee,Linda Eva Amoah
DOI: https://doi.org/10.1186/s12865-024-00607-1
IF: 3
2024-02-11
BMC Immunology
Abstract:Haemoglobin (Hb) variants such as sickle cell trait (SCT/HbAS) play a role in protecting against clinical malaria, but little is known about the development of immune responses against malaria parasite ( Plasmodium falciparum surface protein 230 (Pfs230) and Plasmodium falciparum erythrocyte binding antigen 175 region-3 (PfEBA175-3R)) and vector (on the An. gambiae Salivary Gland Protein-6 peptide 1 (gSG6-P1)) antigens in individuals with variants Hb genotypes. This study assessed antibody (IgG) responses against malaria parasite, Pfs230 and PfEBA175-3R and vector, gSG6-P1 in febrile individuals with variant Hb genotypes.
immunology
What problem does this paper attempt to address?